Joggy K. George, MD
See Publications

Interests

  • Cardiology
  • interventional cardiology
  • transplantation

Education

  • Medical School:

    Ross University School of Medicine

  • Residency:

    Maimonides Medical Center

  • Fellowships:

    Baylor College of Medicine

Academic & Clinical Affiliations

  • Texas Heart & Vascular Specialists, PA

Honors, Awards and Memberships

Publications

4862227 WS63FIXU 1 alternatives-to-animal-experimentation 10 date desc George 1916 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%229SC85ZEF%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Inchaustegui%20et%20al.%22%2C%22parsedDate%22%3A%222022-10-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BInchaustegui%2C%20C.%20A.%2C%20Patel%2C%20A.%2C%20Lamba%2C%20H.%20K.%20et%20al.%20%282022%29.%20Impact%20of%20time%20off%20anticoagulation%20in%20patients%20with%20continuous-flow%20left%20ventricular%20assist%20devices.%20%26lt%3Bi%26gt%3BJ%20Artif%20Organs%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10047-022-01367-8%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10047-022-01367-8%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20time%20off%20anticoagulation%20in%20patients%20with%20continuous-flow%20left%20ventricular%20assist%20devices%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%20A.%22%2C%22lastName%22%3A%22Inchaustegui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashley%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harveen%20K.%22%2C%22lastName%22%3A%22Lamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justin%22%2C%22lastName%22%3A%22Arunthamakun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Ting%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhasis%22%2C%22lastName%22%3A%22Chatterjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%20P.%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%20K.%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%20E.%22%2C%22lastName%22%3A%22Shafii%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%20K.%22%2C%22lastName%22%3A%22Liao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20B.%22%2C%22lastName%22%3A%22Civitello%22%7D%5D%2C%22abstractNote%22%3A%22Patients%20with%20left%20ventricular%20assist%20devices%20%28LVADs%29%20receive%20anticoagulation%20to%20decrease%20the%20risk%20of%20thrombosis.%20Various%20circumstances%20require%20discontinuing%20anticoagulation%20in%20LVAD%20patients%2C%20but%20the%20risks%20entailed%20are%20not%20well%20defined.%20In%20a%20retrospective%20review%20of%20LVAD%20implantation%20procedures%2C%20we%20examined%20the%20effect%20of%20time%20off%20anticoagulation%20on%20thrombosis%20and%20mortality%20rates%20after%20implantation.%20An%20international%20normalized%20ratio%5Cu2009%5Cu2264%5Cu20091.5%20was%20used%20to%20screen%20for%20patients%20taken%20off%20anticoagulation.%20Patients%20were%20divided%20into%20three%20groups%20by%20the%20cumulative%20number%20of%20days%20off%20anticoagulation%3A%20no%20discontinuation%2C%20short-term%20discontinuation%20%28%26lt%3B%5Cu200930%5Cu00a0days%29%2C%20and%20long-term%20discontinuation%20%28%5Cu2265%5Cu200930%5Cu00a0days%29.%20Rates%20of%20ischemic%20stroke%2C%20pump%20thrombosis%2C%20and%20mortality%20were%20compared%20among%20groups.%20Of%20245%20patients%20who%20underwent%20LVAD%20implantation%20during%20the%20study%2C%2070%20%2828.6%25%29%20were%20off%20anticoagulation%20during%20follow-up%3A%2037%20%2815.1%25%29%20had%20short-term%20discontinuation%20%28median%2C%2011%5Cu00a0days%29%2C%20and%2033%20%2813.5%25%29%20had%20long-term%20discontinuation%20%28median%2C%20124%5Cu00a0days%29.%20Patients%20with%20long-term%20discontinuation%20had%20a%20higher%20rate%20of%20ischemic%20stroke%20%28adjusted%20hazard%20ratio%208.5%2C%20p%5Cu2009%3D%5Cu20090.001%29%20and%20death%20%28adjusted%20hazard%20ratio%203.9%2C%20p%5Cu2009%3D%5Cu20090.001%29.%20The%20three%20groups%20did%20not%20differ%20in%20pump%20thrombosis%20rate.%20We%20conclude%20that%20after%20LVAD%20implantation%2C%20discontinuing%20anticoagulation%20for%5Cu2009%5Cu2265%5Cu200930%5Cu00a0days%20is%20independently%20associated%20with%20an%20increased%20risk%20of%20ischemic%20stroke%20and%20death.%22%2C%22date%22%3A%22Oct%2008%2C%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10047-022-01367-8%22%2C%22ISSN%22%3A%221619-0904%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%229FBUJBMU%22%2C%22S7WF6DG3%22%2C%22WS63FIXU%22%2C%22ZMAN8MMI%22%2C%22VCK5HVUS%22%2C%22C2VFJYPK%22%2C%22MDTREPAF%22%5D%2C%22dateModified%22%3A%222022-11-04T15%3A28%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22TL2AQYCP%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Akkanti%20et%20al.%22%2C%22parsedDate%22%3A%222022-09-23%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAkkanti%2C%20B.%2C%20Suarez%2C%20E.%20E.%2C%20O%26%23x2019%3BNeil%2C%20E.%20R.%20et%20al.%20%282022%29.%20Extracorporeal%20membrane%20oxygenation%20for%20COVID-19%3A%20Collaborative%20experience%20from%20the%20Texas%20Medical%20Center%20in%20Houston%20with%202%20years%20follow-up.%20%26lt%3Bi%26gt%3BASAIO%20J%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMAT.0000000000001791%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMAT.0000000000001791%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Extracorporeal%20membrane%20oxygenation%20for%20COVID-19%3A%20Collaborative%20experience%20from%20the%20Texas%20Medical%20Center%20in%20Houston%20with%202%20years%20follow-up%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bindu%22%2C%22lastName%22%3A%22Akkanti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%20E.%22%2C%22lastName%22%3A%22Suarez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erika%20R.%22%2C%22lastName%22%3A%22O%27Neil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aniket%20S.%22%2C%22lastName%22%3A%22Rali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rahat%22%2C%22lastName%22%3A%22Hussain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kha%22%2C%22lastName%22%3A%22Dinh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Divina%20M.%22%2C%22lastName%22%3A%22Tuazon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20E.%22%2C%22lastName%22%3A%22MacGillivray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20L.%22%2C%22lastName%22%3A%22Diaz-Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%20K.%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Biswajit%22%2C%22lastName%22%3A%22Kar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Patrick%20Herlihy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%20E.%22%2C%22lastName%22%3A%22Shafii%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Igor%20D.%22%2C%22lastName%22%3A%22Gregoric%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faisal%22%2C%22lastName%22%3A%22Masud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhasis%22%2C%22lastName%22%3A%22Chatterjee%22%7D%5D%2C%22abstractNote%22%3A%22Patients%20with%20severe%20refractory%20hypoxemic%20respiratory%20failure%20may%20benefit%20from%20extracorporeal%20membrane%20oxygenation%20%28ECMO%29%20for%20salvage%20therapy.%20The%20Coronavirus%20disease%202019%20%28COVID-19%29%20pandemic%20offered%20three%20high-volume%20independent%20ECMO%20programs%20at%20a%20large%20medical%20center%20the%20chance%20to%20collaborate%20to%20optimize%20ECMO%20care%20at%20the%20beginning%20of%20the%20pandemic%20in%20Spring%202020.%20Between%20March%2015%2C%202020%2C%20and%20May%2030%2C%202020%2C%203%2C615%20inpatients%20with%20COVID-19%20were%20treated%20at%20the%20Texas%20Medical%20Center.%20During%20this%20time%2C%2035%20COVID-19%20patients%20were%20cannulated%20for%20ECMO%2C%20all%20but%20one%20in%20a%20veno-venous%20configuration.%20At%20hospital%20discharge%2C%2023%20%2866%25%29%20of%20the%2035%20patients%20were%20alive.%20Twelve%20patients%20died%20of%20vasodilatory%20shock%20%28n%20%3D%209%29%2C%20intracranial%20hemorrhage%20%28n%20%3D%202%29%2C%20and%20cannulation-related%20bleeding%20and%20multiorgan%20dysfunction%20%28n%20%3D%201%29.%20The%20average%20duration%20of%20ECMO%20was%2013.6%20days%20in%20survivors%20and%2025.0%20days%20in%20nonsurvivors%20%28p%20%26lt%3B%200.04%29.%20At%201%20year%20follow-up%2C%20all%2023%20discharged%20patients%20were%20still%20alive%2C%20making%20the%201%20year%20survival%20rate%2066%25%20%2823%5C%2F35%29.%20At%202%20years%20follow-up%2C%20the%20overall%20rate%20of%20survival%20was%2063%25%20%2822%5C%2F35%29.%20Of%20those%20patients%20who%20survived%202%20years%2C%20all%20were%20at%20home%20and%20alive%20and%20well%20at%20follow-up.%22%2C%22date%22%3A%22Sept%2023%2C%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FMAT.0000000000001791%22%2C%22ISSN%22%3A%221538-943X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22AAQ89W3S%22%2C%22WS63FIXU%22%2C%22ZMAN8MMI%22%2C%22BQPL6CIB%22%2C%22VCK5HVUS%22%2C%22MDTREPAF%22%5D%2C%22dateModified%22%3A%222022-11-04T15%3A25%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22P4MWY5W9%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bush%20et%20al.%22%2C%22parsedDate%22%3A%222021-11-01%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBush%2C%20A.%20L.%2C%20Bandeali%2C%20S.%20J.%2C%20Moore%2C%20W.%20et%20al.%20%282021%29.%20Echocardiography%20and%20nuclear%20scintigraphy%20in%20the%20diagnosis%20of%20transthyretin%20cardiac%20amyloidosis.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B48%26lt%3B%5C%2Fi%26gt%3B%2C%20e207279.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-20-7279%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-20-7279%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Echocardiography%20and%20nuclear%20scintigraphy%20in%20the%20diagnosis%20of%20transthyretin%20cardiac%20amyloidosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%20L.%22%2C%22lastName%22%3A%22Bush%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salman%20J.%22%2C%22lastName%22%3A%22Bandeali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Warren%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%20K.%22%2C%22lastName%22%3A%22George%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Nov%201%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-20-7279%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%223AZ57DW6%22%2C%22USMR7XNI%22%2C%22WS63FIXU%22%2C%22Z2Y79GLS%22%2C%22AUPQENLZ%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222022-02-04T15%3A15%3A24Z%22%7D%7D%2C%7B%22key%22%3A%222W7E7626%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rali%20et%20al.%22%2C%22parsedDate%22%3A%222021-04%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRali%2C%20A.%20S.%2C%20Taylor%2C%20Z.%2C%20%26lt%3Bstrong%26gt%3BGeorge%26lt%3B%5C%2Fstrong%26gt%3B%2C%20J.%20et%20al.%20%282021%29.%20Refractory%20hypoxemia%20despite%20extracorporeal%20membrane%20oxygenation.%20%26lt%3Bi%26gt%3BChest%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B159%26lt%3B%5C%2Fi%26gt%3B%2C%20e289%26%23x2013%3Be291.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.chest.2020.08.2138%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.chest.2020.08.2138%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Refractory%20hypoxemia%20despite%20extracorporeal%20membrane%20oxygenation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aniket%20S.%22%2C%22lastName%22%3A%22Rali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zachary%22%2C%22lastName%22%3A%22Taylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergio%22%2C%22lastName%22%3A%22Trevino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20L.%22%2C%22lastName%22%3A%22Diaz-Gomez%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Apr%202021%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.chest.2020.08.2138%22%2C%22ISSN%22%3A%2200123692%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS0012369221002166%22%2C%22collections%22%3A%5B%22WS63FIXU%22%2C%22BQPL6CIB%22%5D%2C%22dateModified%22%3A%222022-02-04T15%3A16%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22TMA8G96M%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parikh%20et%20al.%22%2C%22parsedDate%22%3A%222020-11%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BParikh%2C%20V.%20Y.%2C%20Parikh%2C%20U.%20M.%2C%20Moctezuma-Ramirez%2C%20A.%20et%20al.%20%282020%29.%20Factor%20Xa%20inhibitors%20in%20patients%20with%20continuous-flow%20left%20ventricular%20assist%20devices.%20%26lt%3Bi%26gt%3BGen%20Thorac%20Cardiovasc%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B68%26lt%3B%5C%2Fi%26gt%3B%2C%201278%26%23x2013%3B1284.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11748-020-01371-w%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11748-020-01371-w%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Factor%20Xa%20inhibitors%20in%20patients%20with%20continuous-flow%20left%20ventricular%20assist%20devices%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vishal%20Y.%22%2C%22lastName%22%3A%22Parikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Umang%20M.%22%2C%22lastName%22%3A%22Parikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angel%22%2C%22lastName%22%3A%22Moctezuma-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harveen%20K.%22%2C%22lastName%22%3A%22Lamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%20K.%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Savitri%22%2C%22lastName%22%3A%22Fedson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%20P.%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20Warfarin%20is%20standard%20anticoagulation%20therapy%20for%20patients%20with%20a%20continuous-flow%20left%20ventricular%20assist%20device%20%28CF-LVAD%29.%20However%2C%20warfarin%20requires%20regular%20monitoring%20and%20dosage%20adjustments%20and%20fails%20for%20many%20patients%2C%20causing%20thromboembolic%20and%20bleeding%20events.%20Factor%20Xa%20inhibitors%20have%20been%20shown%20to%20be%20noninferior%20to%20warfarin%20in%20preventing%20strokes%20and%20are%20associated%20with%20less%20intracranial%20hemorrhage%20in%20patients%20with%20atrial%20fibrillation.%20We%20evaluated%20treatment%20safety%20and%20effectiveness%20in%20CF-LVAD%20patients%20who%20switched%20from%20warfarin%20to%20a%20factor%20Xa%20inhibitor%20%28apixaban%20or%20rivaroxaban%29%20after%20warfarin%20failure.%5CnMETHODS%3A%20This%20was%20a%20retrospective%2C%20single-center%20study%20of%20patients%20treated%20between%202008%20and%202018.%20We%20assessed%20the%20occurrence%20of%20stroke%2C%20non-central%20nervous%20system%20%28CNS%29%20embolism%2C%20pump%20thrombosis%2C%20and%20major%20gastrointestinal%20bleeding%20and%20intracranial%20hemorrhage%20during%20therapy.%5CnRESULTS%3A%20We%20identified%20seven%20patients%3A%20five%20were%20male%2C%20the%20average%20body%20mass%20index%20was%2030%5Cu00a0kg%5C%2Fm2%2C%20and%20average%20age%20was%2056%5Cu00a0years.%20Preimplantation%20comorbidities%20included%20hypertension%20%28all%20patients%29%20and%20diabetes%20mellitus%2C%20ischemic%20cardiomyopathy%2C%20atrial%20fibrillation%2C%20and%20previous%20myocardial%20infarction%20%28four%5Cu00a0patients%20each%29.%20Overall%2C%20patients%20received%20warfarin%20for%203968%5Cu00a0days%20and%20apixaban%5C%2Frivaroxaban%20for%201459%5Cu00a0days.%20The%20warfarin%20group%20was%20within%20the%20therapeutic%20INR%20range%20%282.0-3.0%29%2030%25%20of%20the%20time.%20Complication%20rates%20did%20not%20differ%20between%20warfarin%20and%20apixaban%5C%2Frivaroxaban%3A%20strokes%2C%200.20%20vs%20none%2C%20non-CNS%20embolism%2C%200.54%20vs%20none%3B%20pump%20thrombosis%2C%200.27%20vs%20none%3B%20major%20gastrointestinal%20bleeding%2C%200.20%20vs%200.50%3B%20intracranial%20hemorrhage%2C%200.13%20vs%20none.%5CnCONCLUSIONS%3A%20Factor%20Xa%20inhibitors%20may%20be%20viable%20treatment%20options%20for%20CF-LVAD%20patients%20for%20whom%20warfarin%20therapy%20has%20failed.%20Large%20prospective%20studies%20are%20necessary%20to%20confirm%20these%20results.%22%2C%22date%22%3A%22Nov%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs11748-020-01371-w%22%2C%22ISSN%22%3A%221863-6713%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%22TIPQ3BD5%22%2C%22S7WF6DG3%22%2C%2264GCVCDC%22%2C%22WS63FIXU%22%2C%22QZHY2RIG%22%5D%2C%22dateModified%22%3A%222022-02-04T15%3A15%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22IH7GDALN%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22G%5Cu00e9n%5Cu00e9reux%20et%20al.%22%2C%22parsedDate%22%3A%222020-07%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BG%26%23xE9%3Bn%26%23xE9%3Breux%2C%20P.%2C%20Nazif%2C%20T.%20M.%2C%20%26lt%3Bstrong%26gt%3BGeorge%26lt%3B%5C%2Fstrong%26gt%3B%2C%20J.%20K.%20et%20al.%20%282020%29.%20First-in-human%20study%20of%20the%20Saranas%20Early%20Bird%20Bleed%20Monitoring%20System%20for%20the%20detection%20of%20endovascular%20procedure-related%20bleeding%20events.%20%26lt%3Bi%26gt%3BJ%20Invasive%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B32%26lt%3B%5C%2Fi%26gt%3B%2C%20255%26%23x2013%3B261%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22First-in-human%20study%20of%20the%20Saranas%20Early%20Bird%20Bleed%20Monitoring%20System%20for%20the%20detection%20of%20endovascular%20procedure-related%20bleeding%20events%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22G%5Cu00e9n%5Cu00e9reux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tamim%20M.%22%2C%22lastName%22%3A%22Nazif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%20K.%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colin%20M.%22%2C%22lastName%22%3A%22Barker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20T.%22%2C%22lastName%22%3A%22Klodell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20P.%22%2C%22lastName%22%3A%22Slater%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Razavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ken%22%2C%22lastName%22%3A%22Bueche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manesh%20R.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amir%22%2C%22lastName%22%3A%22Kaki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajay%20J.%22%2C%22lastName%22%3A%22Kirtane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zaffer%20A.%22%2C%22lastName%22%3A%22Syed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bart%20E.%22%2C%22lastName%22%3A%22Muhs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dimitri%22%2C%22lastName%22%3A%22Karmpaliotis%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20To%20evaluate%20the%20safety%20and%20accuracy%20of%20the%20Early%20Bird%20Bleed%20Monitoring%20System%20%28EBBMS%3B%20Saranas%29%20for%20the%20detection%20of%20access-site%20related%20bleeds%20in%20humans%20undergoing%20endovascular%20procedures.%5CnBACKGROUND%3A%20Bleeding%20complications%20after%20endovascular%20procedures%20are%20frequent%20and%20associated%20with%20poor%20prognosis.%20The%20EBBMS%20is%20a%20novel%20technology%20designed%20to%20detect%20in%20real%20time%20the%20onset%2C%20progression%2C%20and%20severity%20of%20internal%20bleeds.%5CnMETHODS%3A%20The%20EBBMS%20was%20used%20during%20and%20after%20endovascular%20procedures%2C%20either%20as%20a%20venous%20or%20arterial%20access%20sheath.%20The%20primary%20endpoint%20was%20the%20level%20of%20agreement%20in%20bleed%20detection%20between%20the%20Saranas%20EBBMS%20and%20postprocedural%20computed%20tomography.%5CnRESULTS%3A%20From%20August%202018%20to%20December%202018%2C%20a%20total%20of%2060%20patients%20from%20five%20United%20States%20sites%20were%20enrolled%20and%20underwent%20elective%20endovascular%20procedures%20%28transcatheter%20aortic%20valve%20replacement%20%5B67%25%5D%2C%20percutaneous%20coronary%20intervention%20%5B13%25%5D%2C%20percutaneous%20ventricular%20assist%20device%20%5B8%25%5D%2C%20balloon%20aortic%20valvuloplasty%20%5B7%25%5D%2C%20transcatheter%20mitral%20valve%20repair%5C%2Freplacement%20%5B4%25%5D%2C%20and%20endovascular%20aneurysmal%20repair%20%5B2%25%5D%29.%20The%20EBBMS%20detected%20the%20absence%20of%20bleeds%20in%2021%20patients%20%2835%25%29%20and%20bleeds%20in%2039%20patients%20%2865%25%29%2C%20with%20bleeding%20severity%20level%201%20in%2020%20patients%20%2833%25%29%2C%20level%202%20in%2015%20patients%20%2825%25%29%2C%20and%20level%203%20in%204%20patients%20%287%25%29.%20Bleeding%20detection%20occurred%20during%20the%20procedure%20in%2031%25%20of%20patients%20and%20post%20procedure%20in%2069%25%20of%20patients.%20The%20level%20of%20agreement%20between%20the%20EBBMS%20and%20computed%20tomography%20scan%20was%20high%20%28Cohen%26%23039%3Bs%20kappa%3D0.84%29.%20No%20device-related%20complications%20were%20reported.%5CnCONCLUSIONS%3A%20The%20EBBMS%20was%20safe%20across%20a%20variety%20of%20endovascular%20procedures%20and%20detected%20bleeding%20events%20with%20a%20high%20level%20of%20agreement%20with%20postprocedural%20computed%20tomography%20scan.%22%2C%22date%22%3A%22July%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221557-2501%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MQPA457U%22%2C%22WS63FIXU%22%5D%2C%22dateModified%22%3A%222022-02-04T15%3A15%3A00Z%22%7D%7D%2C%7B%22key%22%3A%223NMRKCAT%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yang%20et%20al.%22%2C%22parsedDate%22%3A%222020-03%22%2C%22numChildren%22%3A8%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BYang%2C%20Y.%2C%20Rali%2C%20A.%20S.%2C%20Inchaustegui%2C%20C.%20et%20al.%20%282020%29.%20Extracorporeal%20membrane%20oxygenation%20in%20coronavirus%20disease%202019-associated%20acute%20respiratory%20distress%20syndrome%3A%20An%20initial%20US%20experience%20at%20a%20high-volume%20centre.%20%26lt%3Bi%26gt%3BCard%20Fail%20Rev%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B6%26lt%3B%5C%2Fi%26gt%3B%2C%20e17.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.15420%5C%2Fcfr.2020.16%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.15420%5C%2Fcfr.2020.16%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Extracorporeal%20membrane%20oxygenation%20in%20coronavirus%20disease%202019-associated%20acute%20respiratory%20distress%20syndrome%3A%20An%20initial%20US%20experience%20at%20a%20high-volume%20centre%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yang%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aniket%20S.%22%2C%22lastName%22%3A%22Rali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Inchaustegui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Javid%22%2C%22lastName%22%3A%22Alakbarli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhasis%22%2C%22lastName%22%3A%22Chatterjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20P.%22%2C%22lastName%22%3A%22Herlihy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%22%2C%22lastName%22%3A%22Shafii%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Mar%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.15420%5C%2Fcfr.2020.16%22%2C%22ISSN%22%3A%222057-7540%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22AAQ89W3S%22%2C%22WS63FIXU%22%2C%22V9VNRSPC%22%2C%22ZMAN8MMI%22%2C%22VCK5HVUS%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222022-02-17T16%3A19%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22KG3ILPM3%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hinds%20et%20al.%22%2C%22parsedDate%22%3A%222019-12%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHinds%2C%20E.%20D.%2C%20Marin%2C%20M.%20J.%2C%20%26lt%3Bstrong%26gt%3BGeorge%26lt%3B%5C%2Fstrong%26gt%3B%2C%20J.%20et%20al.%20%282019%29.%20A%20coronary%20cameral%20fistula%20treated%20with%20coil%20embolization.%20%26lt%3Bi%26gt%3BJRSM%20Cardiovasc%20Dis%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B8%26lt%3B%5C%2Fi%26gt%3B%2C%202048004019856801.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F2048004019856801%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F2048004019856801%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20coronary%20cameral%20fistula%20treated%20with%20coil%20embolization%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethan%20D.%22%2C%22lastName%22%3A%22Hinds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manuel%20J.%22%2C%22lastName%22%3A%22Marin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%22%2C%22lastName%22%3A%22Delgado%22%7D%5D%2C%22abstractNote%22%3A%22A%2056-year-old%20man%20who%20had%20twice%20previously%20undergone%20orthotopic%20heart%20transplantation%20was%20admitted%20with%20dyspnea%20and%20heart%20failure%20symptoms.%20A%20biopsy%20excluded%20rejection.%20Left%20heart%20catheterization%20revealed%20a%20coronary%20cameral%20fistula.%20After%20the%20patient%20was%20given%20mild%20diuretics%2C%20his%20condition%20improved.%20No%20significant%20fistula%20flow%20was%20detected%2C%20and%20he%20was%20discharged.%20Several%20months%20later%2C%20the%20patient%20was%20readmitted%20with%20worsening%20chest%20pain%20and%20dyspnea.%20Left%20ventricular%20end-diastolic%20pressure%20and%20flow%20through%20the%20fistula%20were%20increased.%20To%20correct%20the%20coronary%20cameral%20fistula%2C%20we%20performed%20a%20coil%20embolization%20without%20complications.%20Several%20months%20later%20at%20follow-up%2C%20the%20patient%26%23039%3Bs%20symptoms%20had%20resolved%2C%20and%20his%20left%20ventricular%20end-diastolic%20pressure%20had%20normalized.%20We%20conclude%20that%20coronary%20fistulas%20may%20be%20caused%20by%20trauma%20to%20the%20heart%20during%20the%20de-airing%20process%2C%20which%20may%20be%20prevented%20in%20the%20future%20with%20the%20development%20of%20safer%20and%20more%20effective%20de-airing%20techniques.%22%2C%22date%22%3A%222019%20Jan-Dec%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1177%5C%2F2048004019856801%22%2C%22ISSN%22%3A%222048-0040%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22TIPQ3BD5%22%2C%22WS63FIXU%22%5D%2C%22dateModified%22%3A%222022-02-04T15%3A14%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22HQI7PV4E%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Anjum%20et%20al.%22%2C%22parsedDate%22%3A%222018-09%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAnjum%2C%20A.%2C%20Kurihara%2C%20C.%2C%20Critsinelis%2C%20A.%20et%20al.%20%282018%29.%20Acute%20kidney%20injury%20after%20implantation%20of%20a%20left%20ventricular%20assist%20device%3A%20a%20comparison%20of%20axial-flow%20%28HeartMate%20II%29%20and%20centrifugal-flow%20%28HeartWare%20HVAD%29%20devices.%20%26lt%3Bi%26gt%3BJ%20Artif%20Organs%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B21%26lt%3B%5C%2Fi%26gt%3B%2C%20285%26%23x2013%3B292.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10047-018-1047-0%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10047-018-1047-0%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20kidney%20injury%20after%20implantation%20of%20a%20left%20ventricular%20assist%20device%3A%20a%20comparison%20of%20axial-flow%20%28HeartMate%20II%29%20and%20centrifugal-flow%20%28HeartWare%20HVAD%29%20devices%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azeen%22%2C%22lastName%22%3A%22Anjum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chitaru%22%2C%22lastName%22%3A%22Kurihara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andre%22%2C%22lastName%22%3A%22Critsinelis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masashi%22%2C%22lastName%22%3A%22Kawabori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tadahisa%22%2C%22lastName%22%3A%22Sugiura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20B.%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Whitson%20B.%22%2C%22lastName%22%3A%22Etheridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%20M.%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%20K.%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%20P.%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Morgan%22%7D%5D%2C%22abstractNote%22%3A%22Continuous-flow%20left%20ventricular%20assist%20devices%20%28CF-LVADs%29%20are%20increasingly%20being%20used%20to%20treat%20advanced%2C%20refractory%20chronic%20heart%20failure.%20Herein%2C%20we%20sought%20to%20determine%20the%20incidence%20of%20postoperative%20acute%20kidney%20injury%20%28AKI%29%20in%20axial-flow%20%28HeartMate%20II%3B%20HM-II%29%20and%20centrifugal-flow%20%28HVAD%29%20CF-LVAD%20recipients%2C%20as%20well%20as%20the%20effect%20of%20AKI%20on%20mortality.%20The%20study%20cohort%20comprised%20520%20patients%20who%20received%20a%20HM-II%20%28n%5Cu2009%3D%5Cu2009398%29%20or%20HVAD%20%28n%5Cu2009%3D%5Cu2009122%29%20at%20our%20center%20between%20November%202003%20and%20March%202016.%20Their%20records%20were%20reviewed%20to%20determine%20the%20incidence%20of%20RIFLE-defined%20AKI%20after%20LVAD%20implantation.%20We%20compared%20the%20perioperative%20characteristics%2C%20postoperative%20complications%2C%20and%20survival%20rates%20of%20the%20patients%20with%20and%20without%20AKI%20and%20differentiated%20the%20outcomes%20based%20on%20device%20type%20%28HM-II%20or%20HVAD%29.%20Seventy-five%20patients%20%2814.4%25%29%20developed%20AKI%20postoperatively.%20Patients%20with%20AKI%20after%20LVAD%20implantation%20had%20significantly%20reduced%20survival%20compared%20to%20patients%20without%20AKI%20%28p%5Cu2009%3D%5Cu20090.01%29.%20Cox%20proportional%20hazards%20models%20showed%20that%20AKI%20was%20a%20significant%20independent%20predictor%20of%20mortality%20%28HR%5Cu2009%3D%5Cu20091.54%2C%20p%5Cu2009%3D%5Cu20090.03%29.%20Preoperative%20mechanical%20circulatory%20support%20and%20prolonged%20cardiopulmonary%20bypass%20time%20were%20independent%20predictors%20of%20AKI.%20The%20incidence%20of%20AKI%20was%20similar%20for%20HM-II%20and%20HVAD%20recipients%20%28p%5Cu2009%3D%5Cu20090.25%29.%20There%20was%20no%20significant%20difference%20in%20AKI%20rates%20for%20the%20HM-II%20and%20HVAD%20recipients.%20Developing%20AKI%20adversely%20affected%20survival.%22%2C%22date%22%3A%22Sep%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10047-018-1047-0%22%2C%22ISSN%22%3A%221619-0904%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%229FBUJBMU%22%2C%22TIPQ3BD5%22%2C%22YQCNXVUF%22%2C%22AAQ89W3S%22%2C%22WS63FIXU%22%5D%2C%22dateModified%22%3A%222022-02-04T15%3A14%3A52Z%22%7D%7D%2C%7B%22key%22%3A%2254VQWMZX%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kuten%20and%20George%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKuten%2C%20D.%20and%20%26lt%3Bstrong%26gt%3BGeorge%26lt%3B%5C%2Fstrong%26gt%3B%2C%20J.%20K.%20%282018%29.%20Right%20ventricular%20failure%20in%20patients%20undergoing%20LVAD%20placement.%20In%20J.%20A.%20Morgan%2C%20A.%20B.%20Civitello%20and%20O.%20H.%20Frazier%20%28eds.%29%2C%20%26lt%3Bi%26gt%3BMechanical%20Circulatory%20Support%20for%20Advanced%20Heart%20Failure%26lt%3B%5C%2Fi%26gt%3B%20%28251%26%23x2013%3B261%29.%20Cham%3A%20Springer%20International%20Publishing.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2F978-3-319-65364-8_18.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Right%20ventricular%20failure%20in%20patients%20undergoing%20LVAD%20placement%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Morgan%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Andrew%20B.%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22O.H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Kuten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%20K.%22%2C%22lastName%22%3A%22George%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22bookTitle%22%3A%22Mechanical%20Circulatory%20Support%20for%20Advanced%20Heart%20Failure%22%2C%22date%22%3A%222018%22%2C%22language%22%3A%22en%22%2C%22ISBN%22%3A%22978-3-319-65363-1%20978-3-319-65364-8%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flink.springer.com%5C%2F10.1007%5C%2F978-3-319-65364-8_18%22%2C%22collections%22%3A%5B%22MVVC37IS%22%2C%22WS63FIXU%22%5D%2C%22dateModified%22%3A%222019-01-08T15%3A53%3A23Z%22%7D%7D%5D%7D
Inchaustegui, C. A., Patel, A., Lamba, H. K. et al. (2022). Impact of time off anticoagulation in patients with continuous-flow left ventricular assist devices. J Artif Organs. https://doi.org/10.1007/s10047-022-01367-8.
Akkanti, B., Suarez, E. E., O’Neil, E. R. et al. (2022). Extracorporeal membrane oxygenation for COVID-19: Collaborative experience from the Texas Medical Center in Houston with 2 years follow-up. ASAIO J. https://doi.org/10.1097/MAT.0000000000001791.
Bush, A. L., Bandeali, S. J., Moore, W. et al. (2021). Echocardiography and nuclear scintigraphy in the diagnosis of transthyretin cardiac amyloidosis. Tex Heart Inst J 48, e207279. https://doi.org/10.14503/THIJ-20-7279.
Rali, A. S., Taylor, Z., George, J. et al. (2021). Refractory hypoxemia despite extracorporeal membrane oxygenation. Chest 159, e289–e291. https://doi.org/10.1016/j.chest.2020.08.2138.
Parikh, V. Y., Parikh, U. M., Moctezuma-Ramirez, A. et al. (2020). Factor Xa inhibitors in patients with continuous-flow left ventricular assist devices. Gen Thorac Cardiovasc Surg 68, 1278–1284. https://doi.org/10.1007/s11748-020-01371-w.
Généreux, P., Nazif, T. M., George, J. K. et al. (2020). First-in-human study of the Saranas Early Bird Bleed Monitoring System for the detection of endovascular procedure-related bleeding events. J Invasive Cardiol 32, 255–261
Yang, Y., Rali, A. S., Inchaustegui, C. et al. (2020). Extracorporeal membrane oxygenation in coronavirus disease 2019-associated acute respiratory distress syndrome: An initial US experience at a high-volume centre. Card Fail Rev 6, e17. https://doi.org/10.15420/cfr.2020.16.
Hinds, E. D., Marin, M. J., George, J. et al. (2019). A coronary cameral fistula treated with coil embolization. JRSM Cardiovasc Dis 8, 2048004019856801. https://doi.org/10.1177/2048004019856801.
Anjum, A., Kurihara, C., Critsinelis, A. et al. (2018). Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices. J Artif Organs 21, 285–292. https://doi.org/10.1007/s10047-018-1047-0.
Kuten, D. and George, J. K. (2018). Right ventricular failure in patients undergoing LVAD placement. In J. A. Morgan, A. B. Civitello and O. H. Frazier (eds.), Mechanical Circulatory Support for Advanced Heart Failure (251–261). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-319-65364-8_18.